P2X7 receptor promotes migration and invasion of non-small cell lung cancer A549 cells through the PI3K/Akt pathways

[1]  Wen-jun Zhang,et al.  PI3K/Akt/GSK-3β signal pathway is involved in P2X7 receptor-induced proliferation and EMT of colorectal cancer cells. , 2021, European journal of pharmacology.

[2]  R. Akundi,et al.  Extracellular ATP Mediates Cancer Cell Migration and Invasion Through Increased Expression of Cyclooxygenase 2 , 2021, Frontiers in Pharmacology.

[3]  E. Imyanitov,et al.  Molecular testing and targeted therapy for non-small cell lung cancer: current status and perspectives. , 2020, Critical reviews in oncology/hematology.

[4]  Wen-jun Zhang,et al.  Activation of P2×7 Receptor Promotes the Invasion and Migration of Colon Cancer Cells via the STAT3 Signaling , 2020, Frontiers in Cell and Developmental Biology.

[5]  F. Di Virgilio,et al.  Extracellular ATP: A Feasible Target for Cancer Therapy , 2020, Cells.

[6]  Jin-jian Lu,et al.  Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms. , 2020, Pharmacology & therapeutics.

[7]  M. Calik,et al.  P2X7 receptor as an independent prognostic indicator in gastric cancer , 2020, Bosnian journal of basic medical sciences.

[8]  Wen-jun Zhang,et al.  Effect of P2X7 receptor on tumorigenesis and its pharmacological properties. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[9]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[10]  Xiaozhuo Chen,et al.  Extracellular and macropinocytosis internalized ATP work together to induce epithelial–mesenchymal transition and other early metastatic activities in lung cancer , 2019, Cancer Cell International.

[11]  Ying Zhang,et al.  The role of P2X7 receptor in prognosis and metastasis of colorectal cancer. , 2019, Advances in medical sciences.

[12]  Ahmedin Jemal,et al.  Cancer treatment and survivorship statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[13]  Gregory Riely,et al.  Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review. , 2019, JAMA.

[14]  V. Morsch,et al.  ADA activity is decreased in lymphocytes from patients with advanced stage of lung cancer , 2019, Medical Oncology.

[15]  Yin-Guang Fan,et al.  P2X7 receptor: A potential therapeutic target for autoimmune diseases. , 2019, Autoimmunity reviews.

[16]  R. Weinberg,et al.  EMT and Cancer: More Than Meets the Eye. , 2019, Developmental cell.

[17]  W. Lili,et al.  Highlight Article: P2RX7 functions as a putative biomarker of gastric cancer and contributes to worse prognosis , 2019, Experimental biology and medicine.

[18]  G. Eapen,et al.  Lung Cancer. , 2019, The Medical clinics of North America.

[19]  F. Di Virgilio,et al.  P2X7 Receptor Expression in Patients With Serositis Related to Systemic Lupus Erythematosus , 2019, Front. Pharmacol..

[20]  Yong Yang,et al.  Highly‐expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β‐catenin and mTOR/HIF1α/VEGF signaling , 2019, International journal of cancer.

[21]  Yang Ding,et al.  KIAA1199 promotes invasion and migration in non-small-cell lung cancer (NSCLC) via PI3K-Akt mediated EMT , 2018, Journal of Molecular Medicine.

[22]  F. Di Virgilio,et al.  ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival , 2018, Oncogene.

[23]  Roy S. Herbst,et al.  The biology and management of non-small cell lung cancer , 2018, Nature.

[24]  M. Ji,et al.  Involvement of P2X7 Receptor in Proliferation and Migration of Human Glioma Cells , 2018, BioMed research international.

[25]  S. Gadgeel,et al.  Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer , 2018, Expert review of anticancer therapy.

[26]  Mohini Singh,et al.  EMT: Mechanisms and therapeutic implications , 2017, Pharmacology & therapeutics.

[27]  S. Iqbal,et al.  Therapeutic Uses of HSP90 Inhibitors in Non-Small Cell Lung Carcinoma (NSCLC). , 2018, Current drug metabolism.

[28]  Jia He.  Knocking down MiR-15a expression promotes the occurrence and development and induces the EMT of NSCLC cells in vitro , 2017, Saudi journal of biological sciences.

[29]  C. Presley,et al.  Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults , 2017, Current Oncology Reports.

[30]  F. Di Virgilio,et al.  The P2X7 Receptor in Infection and Inflammation , 2017, Immunity.

[31]  Baoying Hu,et al.  High expression of P2X7R is an independent postoperative indicator of poor prognosis in colorectal cancer. , 2017, Human pathology.

[32]  F. Virgilio,et al.  Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells , 2016, Oncotarget.

[33]  I. Novak,et al.  Targeting of the P2X7 receptor in pancreatic cancer and stellate cells , 2016, International journal of cancer.

[34]  F. Di Virgilio,et al.  P2 receptors in cancer progression and metastatic spreading. , 2016, Current opinion in pharmacology.

[35]  E. C. Naylor,et al.  Targeted Therapy and Immunotherapy for Lung Cancer. , 2016, Surgical oncology clinics of North America.

[36]  F. Di Virgilio,et al.  Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death , 2016, Scientific Reports.

[37]  R. Gómez-Villafuertes,et al.  PI3K/Akt signaling pathway triggers P2X7 receptor expression as a pro-survival factor of neuroblastoma cells under limiting growth conditions , 2015, Scientific Reports.

[38]  M. Idzko,et al.  Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer. , 2015, Lung cancer.

[39]  I. Novak,et al.  The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells , 2015, Molecular Cancer.

[40]  H. Ulrich,et al.  Extracellular nucleotides as novel, underappreciated pro-metastatic factors that stimulate purinergic signaling in human lung cancer cells , 2015, Molecular Cancer.

[41]  Chunhua Luo,et al.  Expression of P2X7R in breast cancer tissue and the induction of apoptosis by the gene-specific shRNA in MCF-7 cells. , 2015, Experimental and therapeutic medicine.

[42]  Li Tang,et al.  P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway. , 2015, Oncology reports.

[43]  M. Bellini,et al.  Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders. , 2015, Pharmacogenomics.

[44]  B. Hyman,et al.  Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation , 2015, Cell Death and Differentiation.

[45]  G. Alí,et al.  P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value , 2014, Oncology letters.

[46]  Yan Liu,et al.  P2X7 Mediates ATP-Driven Invasiveness in Prostate Cancer Cells , 2014, PloS one.

[47]  A. García-Carrancá,et al.  Paracrine Stimulation of P2X7 Receptor by ATP Activates a Proliferative Pathway in Ovarian Carcinoma Cells , 2014, Journal of cellular biochemistry.

[48]  G. Alí,et al.  P2X7 protein expression and polymorphism in non-small cell lung cancer (NSCLC) , 2014, Journal of Negative Results in BioMedicine.

[49]  A. Whetton,et al.  The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets. , 2014, Cancer treatment reviews.

[50]  M. Tsukimoto,et al.  Autocrine signaling via release of ATP and activation of P2X7 receptor influences motile activity of human lung cancer cells , 2014, Purinergic Signalling.

[51]  Hyun B Choi,et al.  Purinergic responses of calcium-dependent signaling pathways in cultured adult human astrocytes , 2014, BMC Neuroscience.

[52]  D. Richel,et al.  Protease‐activated receptor‐2 induces migration of pancreatic cancer cells in an extracellular ATP‐dependent manner , 2013, Journal of thrombosis and haemostasis : JTH.

[53]  M. Cayuela,et al.  Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors. , 2013, Carcinogenesis.

[54]  B. Zhang,et al.  P2X7R suppression promotes glioma growth through epidermal growth factor receptor signal pathway. , 2013, The international journal of biochemistry & cell biology.

[55]  S. Robson,et al.  P2X7 Integrates PI3K/AKT and AMPK-PRAS40-mTOR Signaling Pathways to Mediate Tumor Cell Death , 2013, PloS one.

[56]  P. Pelegrín,et al.  The participation of plasma membrane hemichannels to purinergic signaling. , 2013, Biochimica et biophysica acta.

[57]  A. Taly,et al.  Moving through the gate in ATP-activated P2X receptors. , 2013, Trends in biochemical sciences.

[58]  R. Coutinho-Silva,et al.  Extracellular ATP induces cell death in human intestinal epithelial cells. , 2012, Biochimica et biophysica acta.

[59]  Mitsuru Sato,et al.  Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7. , 2012, European journal of pharmacology.

[60]  Keisuke Sawada,et al.  Autocrine regulation of TGF-&bgr;1-induced cell migration by exocytosis of ATP and activation of P2 receptors in human lung cancer cells , 2012, Journal of Cell Science.

[61]  G. Burnstock,et al.  P2X7 receptors: channels, pores and more. , 2012, CNS & neurological disorders drug targets.

[62]  F. Crews,et al.  ATP‐P2X7 receptor signaling controls basal and TNFα‐stimulated glial cell proliferation , 2012, Glia.

[63]  M. Russo,et al.  Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B. , 2011, Carcinogenesis.

[64]  M. Cayuela,et al.  P2X7 receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness , 2011, Oncogene.

[65]  G. Lenz,et al.  Characterization of ATP‐induced cell death in the GL261 mouse glioma , 2010, Journal of cellular biochemistry.

[66]  G. Burnstock.  Purinergic signalling: past, present and future. , 2008, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[67]  F. Di Virgilio,et al.  Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase , 2008, PloS one.

[68]  Hyun B Choi,et al.  Expression and function of the P2X(7) receptor in rat C6 glioma cells. , 2008, Cancer letters.

[69]  F. Di Virgilio,et al.  Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease? , 2008, Endocrinology.

[70]  J. Testa,et al.  Perturbations of the AKT signaling pathway in human cancer , 2005, Oncogene.

[71]  J. Neary,et al.  P2X7 receptors stimulate AKT phosphorylation in astrocytes , 2004, British journal of pharmacology.

[72]  D. Ferrari,et al.  Cytolytic P2X purinoceptors , 1998, Cell Death and Differentiation.

[73]  G. Burnstock.  The past, present and future of purine nucleotides as signalling molecules , 1997, Neuropharmacology.